Brief: Australia's ACCC Says ACL'S Proposed Acquisition Of Healius Raises Concerns

Healius

20/07/2023 02:28

July 20 (Reuters) - Australian Competition and Consumer
Commission (ACCC):
    * ACL'S PROPOSED ACQUISITION OF HEALIUS RAISES CONCERNS
    * HAS OUTLINED SIGNIFICANT PRELIMINARY COMPETITION CONCERNS
WITH
AUSTRALIAN CLINICAL LABS LIMITED’S PROPOSED ACQUISITION OF
HEALIUS
    * CONCERNED THAT PROPOSED ACQUISITION WOULD BE LIKELY TO
SUBSTANTIALLY LESSEN COMPETITION IN AUSTRALIAN PATHOLOGY
SERVICES MARKETS
    * PROPOSED ACQUISITION WOULD COMBINE TWO OF TOP THREE
PROVIDERS OF
PATHOLOGY SERVICES, INCREASING CONCENTRATION IN ALREADY
CONCENTRATED MARKETS
    * ACCC INVITES SUBMISSIONS IN RESPONSE TO THE STATEMENT OF
ISSUES
BY 10 AUGUST 2023
    * PRELIMINARY VIEW IS COMBINED ACL AND HEALIUS MAY BE ABLE
TO
INCREASE PRICES OR REDUCE SERVICE QUALITY IN BIDS FOR PUBLIC
HOSPITAL TENDERS


Further company coverage:  ACL.AX 

 ((Reuters.Briefs@thomsonreuters.com;))